Cite

HARVARD Citation

    Canale, M. et al. (n.d.). 1846PRole of TP53 mutations in relation to response to anti-ALK agents in EML4-ALK-translocated NSCLC patients. Annals of oncology. p. . [Online]. 
  
Back to record